LianBio
OTC: LIANY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Adam Leo Stone
- Employees
- 163
- Headquarters
- Princeton, United States
- IPO year
- 2021
- Market cap
- $17.4M
- Website
- https://www.lianbio.com
Loading LIANY…
Loading profile data…Frequently asked questions about LIANY
What does LianBio (LIANY) do?
LianBio is a biopharmaceutical firm dedicated to advancing and marketing therapeutic agents across various critical health sectors, including cardiovascular disorders, oncology, ophthalmological conditions, and inflammatory ailments. Its operations are primarily concentrated in China and the broader Asian region. The company's pipeline features...
Where does LIANY trade?
LianBio (LIANY) trades on the Other OTC.
What sector is LIANY in?
LianBio (LIANY) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of LianBio?
Adam Leo Stone is the chief executive officer of LianBio (LIANY).
Where is LianBio headquartered?
LianBio is headquartered in United States.
Does LIANY pay a dividend?
Yes — LianBio (LIANY) paid a trailing twelve-month dividend of USD 0.43 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did LIANY go public?
LianBio (LIANY) completed its initial public offering in 2021.